Cerebral Creatine Deficiencies: A Group of Treatable Intellectual Developmental Disorders
The DOI matches its Crossref record.
Abstract
Currently there are 91 treatable inborn errors of metabolism that cause intellectual developmental disorders. Cerebral creatine deficiencies (CDD) comprise three of these: arginine: glycine amidinotransferase [AGAT], guanidinoacetate methyltransferase [GAMT], and X-linked creatine transporter deficiency [SLC6A8]. Intellectual developmental disorder and cerebral creatine deficiency are the hallmarks of CDD. Additional clinical features include prominent speech delay, autism, epilepsy, extrapyramidal movement disorders, and signal changes in the globus pallidus. Patients with GAMT deficiency exhibit the most severe clinical spectrum. Myopathy is a distinct feature in AGAT deficiency. Guanidinoacetate (GAA) is the immediate product in the creatine biosynthetic pathway. Low GAA concentrations in urine, plasma, and cerebrospinal fluid are characteristic diagnostic markers for AGAT deficiency, while high GAA concentrations are characteristic markers for GAMT deficiency. An elevated ratio of urinary creatine /creatinine excretion serves as a diagnostic marker in males with SLC6A8 deficiency. Treatment strategies include oral supplementation of high-dose creatine-monohydrate for all three CDD. Guanidinoacetate-reducing strategies (high-dose ornithine, arginine-restricted diet) are additionally employed in GAMT deficiency. Supplementation of substrates for intracerebral creatine synthesis (arginine, glycine) has been used additionally to treat SLC6A8 deficiency. Early recognition and treatment improves outcomes. Normal outcomes in neonatally ascertained siblings from index families with AGAT and GAMT deficiency suggest a potential benefit of newborn screening for these disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These findings and others provide promise that high-dose creatine monohydrate supplementation may be an effective adjunctive therapy for children and adults with creatine synthesis deficiencies [18, 145, 157–159].”
From International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine (2017) · cites this paper as [145]
In the citing paper
“While similar in nature, AGAT deficiency is extremely rare with only 20 documented cases worldwide [52].”
From Creatine Supplementation in Children and Adolescents (2021) · cites this paper as [52]
In the citing paper
“This class of syndromes results in a reduction or inability to endogenously synthesize creatine leading low levels of creatine and phosphocreatine in the muscle and brain.”
From Safety of Creatine Supplementation in Active Adolescents and Youth: A Brief Review (2018) · cites this paper as [93]
In the citing paper
“As a result, they often have clinical manifestations of muscle myopathies, gyrate atrophy, movement disorders, speech delay, autism, mental retardation, epilepsy, and/or developmental problems [13, 17, 145].”
From International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine (2017) · cites this paper as [145]
In the citing paper
“These studies generally show some improvement in clinical outcomes particularly for AGAT and GAMT with less consistent effects on CRTR deficiencies [145].”
From International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine (2017) · cites this paper as [145]
7 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Still being checked.
Cited by
Kreider, R. B., Kalman, D. S., Antonio, J., Ziegenfuss, T. N., Wildman, R., Collins, R., Candow, D. G., Kleiner, S. M., Almada, A. L., & Lopez, H. L. (2017) · Journal of the International Society of Sports Nutrition · doi:10.1186/s12970-017-0173-z · Cited by 1,057
“As a result, they often have clinical manifestations of muscle myopathies, gyrate atrophy, movement disorders, speech delay, autism, mental retardation, epilepsy, and/or developmental problems [13, 17, 145].”
BackgroundCreatine in health and disease
Kreider, R. B., & Stout, J. R. (2021) · Nutrients · doi:10.3390/nu13020447 · Cited by 227
Treatable inherited rare movement disorders
Jinnah, H. A., Albanese, A., Bhatia, K. P., Cardoso, F., Prat, G. D., de Koning, T. J., Espay, A. J., Fung, V. S. C., Ruiz, P., Gershanik, O. S., et al. (2017) · Movement Disorders · doi:10.1002/mds.27140 · Cited by 102
Inborn Errors of Metabolism and Epilepsy: Current Understanding, Diagnosis, and Treatment Approaches
Sharma, S., & Prasad, A. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18071384 · Cited by 96
Current and potential new treatment strategies for creatine deficiency syndromes
Fernandes-Pires, G., & Braissant, O. (2022) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2021.12.005 · Cited by 72
Metadata
- Authors
- van Karnebeek, C., & Stockler-Ipsiroglu, S.
- Affiliations
- Division of Biochemical Diseases, Department of Pediatrics, BC Children's Hospital, University of British Columbia, Vancouver, Canada
- Venue
- Seminars in Neurology
- Publisher
- Georg Thieme Verlag KG
- Published
- 2014-09-05
- Volume
- 34
- Issue
- 03
- Pages
- 350-356
- ISSN
- 0271-8235 (ISSN-L)
- 1098-9021
- OpenAlex
- W2027428988
- Cited by
- 72
- References
- 0
- Citations by year
- 2026: 4 · 2025: 10 · 2024: 7 · 2023: 9 · 2022: 7 · 2021: 7 · 2020: 5 · 2019: 4 · 2018: 6 · 2017: 6 · 2016: 6 · 2014: 1
- FWCI
- 2.98
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Seminars in Neurology (publishedVersion)
- PubMed (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Pure Amsterdam UMC (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
- Keywords
- intellectual disability, guanidinoacetate methyltransferase deficiency, SLC6A8, guanidinoacetic acid, creatine synthesis, creatine supplementation, myopathy, speech delay, autism spectrum disorder, epilepsy, globus pallidus, newborn screening, inborn errors of metabolism
- MeSH terms
- Amidinotransferases, Creatine, Humans, Language Development Disorders, Intellectual Disability, Movement Disorders, Brain Diseases, Metabolic, Inborn, X-Linked Intellectual Disability, Plasma Membrane Neurotransmitter Transport Proteins, Guanidinoacetate N-Methyltransferase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cerebral Creatine Deficiencies: A Group of Treatable Intellectual Developmental Disorders. https://app.cochat.ai/papers/10.1055/s-0034-1386772
- The paper
- van Karnebeek, C., & Stockler-Ipsiroglu, S. (2014). Cerebral Creatine Deficiencies: A Group of Treatable Intellectual Developmental Disorders. Seminars in Neurology. https://doi.org/10.1055/s-0034-1386772
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.